Progression in circulating tumor DNA detection for minimal residual disease in patients with colorectal cancer liver metastasis
10.16139/j.1007-9610.2025.04.10
- VernacularTitle:循环肿瘤DNA检测微小残留病灶在结肠直肠癌肝转移中的应用进展
- Author:
Yaqi LI
;
Shaobo MO
;
Junjie PENG
- Publication Type:Journal Article
- From:
Journal of Surgery Concepts & Practice
2025;30(4):351-357
- CountryChina
- Language:Chinese
-
Abstract:
As a non-invasive biomarker, circulating tumor DNA (ctDNA) can sensitively identify minimal residual disease (MRD), offering a novel approach for prognosis prediction and efficacy evaluation in patients with colorectal cancer liver metastasis (CRLM), thereby aiding in the formulation of personalized treatment strategies. This article summarized the progress in the application of ctDNA detection for MRD in CRLM and provided insights into its future directions.
